Home › Trial NCT00559507
Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery
- Trial IDNCT00559507
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorNational Cancer Institute (NCI)
- Enrollment12
- Start date2007-10
- ConditionsEstrogen Receptor-negative Breast Cancer · Male Breast Cancer · Progesterone Receptor-negative Breast Cancer · Recurrent Breast Cancer · Stage IIIB Breast Cancer · Stage IIIC Breast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.